
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current ARGNF market cap is 38.69B. The company's latest EPS is USD 15.0180 and P/E is 36.13.
Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 64.91M | 539.42M | 445.27M | 1.27B | 2.25B |
Operating Income | -477.62M | -348.75M | -720.34M | -425.05M | -21.65M |
Net Income | -608.46M | -408.27M | -709.59M | -295.05M | 833.04M |
Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 2.28B | 2.85B | 3.13B | 4.54B | 6.2B |
Total Liabilities | 605.36M | 316.05M | 320.56M | 444.95M | 704.24M |
Total Equity | 1.67B | 2.53B | 2.81B | 4.1B | 5.5B |
Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -398.46M | -606.81M | -862.81M | -420.33M | -82.75M |
Investing | 344.69M | -347.07M | -461.18M | 308.21M | -717.59M |
Financing | 833M | 1.12B | 843.76M | 1.34B | 279.76M |
Market Cap | 38.69B |
Price to Earnings Ratio | 36.13 |
Price to Sales Ratio | 13.36 |
Price to Cash Ratio | 20.07 |
Price to Book Ratio | 5.47 |
Dividend Yield | - |
Shares Outstanding | 55.47M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | 81.74% |
52 Week High | 697.42 |
52 Week Low | 373.50 |
Spread (Intraday) | 286.96 (41.15%) |
Company Name | Argen X NV (PK) |
Address |
laarderhoogtweg 25 amsterdam, north holland 1101 EB |
Website | https://www.argenx.com |
Industry | coml physical, biologcl resh (8731) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions